+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Palatin Technologies Inc (PTN) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Palatin Technologies Inc (PTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Palatin Technologies Inc (Palatin) is a biopharmaceutical company that develops receptor specific peptide therapeutics. The company's medicines are based on molecules that control the activity of the melanocortin and natriuretic peptide receptor systems. Its lead product includes Vyleesi, indicated for the treatment of premenopausal women with hypoactive sexual desire disorder. Palatin clinical pipeline includes melanocortin receptor programs such as PL-8177 MC1r Agonist (oral) for inflammatory bowel disease; PL9643 MCr Agonist for dry eye diseases; PL-8177 MC1r Agonist (systemic) for Covid-19 infection; and MC4r Agonist for diabetic retinopathy. Its natriuretic peptide receptor programs include PL-3994 NPR-A for heart failure and PL-5028 NPR-A/C Agonist for heart failure and fibrosis. Palatin is headquartered in Cranbury, New Jersey, the US.

Palatin Technologies Inc Key Recent Developments

  • Nov 14, 2022: Palatin Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
  • Oct 13, 2022: Palatin Announces Preliminary First Quarter Fiscal 2023 Vyleesi Product Sales Results
  • Sep 22, 2022: Palatin Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
  • May 17, 2022: Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Palatin Technologies Inc - Key Facts
  • Palatin Technologies Inc - Key Employees
  • Palatin Technologies Inc - Key Employee Biographies
  • Palatin Technologies Inc - Major Products and Services
  • Palatin Technologies Inc - History
  • Palatin Technologies Inc - Company Statement
  • Palatin Technologies Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Palatin Technologies Inc - Business Description
  • R&D Overview
  • Palatin Technologies Inc - Corporate Strategy
  • Palatin Technologies Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Palatin Technologies Inc - Strengths
  • Palatin Technologies Inc - Weaknesses
  • Palatin Technologies Inc - Opportunities
  • Palatin Technologies Inc - Threats
  • Palatin Technologies Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Palatin Technologies Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Nov 14, 2022: Palatin Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
  • Oct 13, 2022: Palatin Announces Preliminary First Quarter Fiscal 2023 Vyleesi Product Sales Results
  • Sep 22, 2022: Palatin Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
  • May 17, 2022: Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
  • Feb 15, 2022: Palatin Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
  • Nov 15, 2021: Palatin Reports First Quarter Fiscal Year 2022 Results and Provides Corporate Update
  • Oct 22, 2021: Palatin awarded"Top 10 Poster" designation at the American Society of Retina Specialists (ASRS) 2021 Annual Meeting
  • Sep 29, 2021: Palatin Reports Fourth Quarter and Full Year Fiscal Year 2021 Financial Results and Provides Corporate Update
  • Sep 27, 2021: Palatin announces presentation of positive protective effects of PL8331 and PL9654 on retinal inflammation at the 2021 American Society of Retina Specialists (ASRS) Annual Meeting
  • Sep 24, 2021: Palatin To Report Fourth Quarter And Fiscal Year End 2021 Results; Teleconference And Webcast To Be Held On September 29, 2021
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Palatin Technologies Inc, Key Facts
  • Palatin Technologies Inc, Key Employees
  • Palatin Technologies Inc, Key Employee Biographies
  • Palatin Technologies Inc, Major Products and Services
  • Palatin Technologies Inc, History
  • Palatin Technologies Inc, Subsidiaries
  • Palatin Technologies Inc, Key Competitors
  • Palatin Technologies Inc, Annual Ratios
  • Palatin Technologies Inc, Interim Ratios
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Palatin Technologies Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Palatin Technologies Inc, Performance Chart (2018 - 2022)
  • Palatin Technologies Inc, Ratio Charts
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Neurocrine Biosciences Inc
  • Stemline Therapeutics Inc
  • ArQule Inc
  • MEI Pharma Inc
  • AcelRx Pharmaceuticals Inc
  • Rigel Pharmaceuticals Inc
  • Calithera Biosciences Inc
  • Savara Inc
  • Protagonist Therapeutics Inc
  • Johnson & Johnson
  • Ardelyx Inc
  • Savara Inc
  • Rigel Pharmaceuticals Inc
  • Calithera Biosciences Inc
  • MEI Pharma Inc
  • AcelRx Pharmaceuticals Inc
  • Ardelyx Inc
  • Protagonist Therapeutics Inc
  • Neurocrine Biosciences Inc
  • Stemline Therapeutics Inc
  • Johnson & Johnson
  • ArQule Inc